Research programme: long-acting glucagon-like peptide-1 - PharmaIN

Drug Profile

Research programme: long-acting glucagon-like peptide-1 - PharmaIN

Alternative Names: PGC GLP-1

Latest Information Update: 16 Jul 2016

Price : $50

At a glance

  • Originator PharmaIN
  • Class Glucagon-like peptides
  • Mechanism of Action Glucagon like peptide 1 receptor agonists
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

    No

Highest Development Phases

  • No development reported Type 1 diabetes mellitus; Type 2 diabetes mellitus

Most Recent Events

  • 16 Jul 2016 No recent reports of development identified for preclinical development in Type-1 diabetes mellitus in USA (SC, Injection)
  • 16 Jul 2016 No recent reports of development identified for preclinical development in Type-2-diabetes-mellitus in USA (SC, Injection)
  • 19 Jul 2007 Preclinical trials in Type-1-diabetes-mellitus in USA (SC)
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top